Sign In

Login

Password

Forgot Password ? Sign Up

CXCL9 (Czech Wikipedia)

Analysis of information sources in references of the Wikipedia article "CXCL9" in Czech language version.

refsWebsite
Global rank Czech rank
10doi.org
2nd place
4th place
7nih.gov
4th place
8th place
7worldcat.org
5th place
3rd place
2elsevier.com
610th place
203rd place
2aacrjournals.org
8,869th place
8,116th place
2nature.com
234th place
72nd place
1oncotarget.com
low place
6,523rd place
1jimmunol.org
low place
5,054th place
1jci.org
low place
7,867th place
1wiley.com
222nd place
83rd place

aacrjournals.org (Global: 8,869th place; Czech: 8,116th place)

cancerres.aacrjournals.org

doi.org (Global: 2nd place; Czech: 4th place)

  • TOKUNAGA, Ryuma; ZHANG, Wu; NASEEM, Madiha. CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation – A target for novel cancer therapy. Cancer Treatment Reviews. 2018-2, roč. 63, s. 40–47. Dostupné online [cit. 2019-04-30]. doi:10.1016/j.ctrv.2017.11.007. PMID 29207310. (anglicky) 
  • SCHOENBORN, Jamie R.; WILSON, Christopher B. Regulation of Interferon‐γ During Innate and Adaptive Immune Responses. Svazek 96. [s.l.]: Elsevier Dostupné online. ISBN 9780123737090. doi:10.1016/s0065-2776(07)96002-2. S. 41–101. (anglicky) DOI: 10.1016/S0065-2776(07)96002-2. 
  • FERNANDEZ-POMA, Sarita M.; SALAS-BENITO, Diego; LOZANO, Teresa. Expansion of Tumor-Infiltrating CD8 + T cells Expressing PD-1 Improves the Efficacy of Adoptive T-cell Therapy. Cancer Research. 2017-07-01, roč. 77, čís. 13, s. 3672–3684. Dostupné online [cit. 2019-04-30]. ISSN 0008-5472. doi:10.1158/0008-5472.CAN-17-0236. (anglicky) 
  • ZHU, Guiquan; YAN, H. Hannah; PANG, Yanli. CXCR3 as a molecular target in breast cancer metastasis: inhibition of tumor cell migration and promotion of host anti-tumor immunity. Oncotarget. 2015-12-22, roč. 6, čís. 41. Dostupné online [cit. 2019-04-30]. ISSN 1949-2553. doi:10.18632/oncotarget.6125. PMID 26485767. (anglicky) 
  • GORBACHEV, A. V.; KOBAYASHI, H.; KUDO, D. CXC Chemokine Ligand 9/Monokine Induced by IFN- Production by Tumor Cells Is Critical for T Cell-Mediated Suppression of Cutaneous Tumors. The Journal of Immunology. 2007-02-15, roč. 178, čís. 4, s. 2278–2286. Dostupné online [cit. 2019-04-30]. ISSN 0022-1767. doi:10.4049/jimmunol.178.4.2278. (anglicky) 
  • ZOHAR, Yaniv; WILDBAUM, Gizi; NOVAK, Rostislav. CXCL11-dependent induction of FOXP3-negative regulatory T cells suppresses autoimmune encephalomyelitis. Journal of Clinical Investigation. 2014-05-01, roč. 124, čís. 5, s. 2009–2022. Dostupné online [cit. 2019-04-30]. ISSN 0021-9738. doi:10.1172/JCI71951. PMID 24713654. (anglicky) 
  • OGHUMU, Steve; VARIKUTI, Sanjay; TERRAZAS, Cesar. CXCR3 deficiency enhances tumor progression by promoting macrophage M2 polarization in a murine breast cancer model. Immunology. 2014-9, roč. 143, čís. 1, s. 109–119. Dostupné online [cit. 2019-04-30]. doi:10.1111/imm.12293. PMID 24679047. (anglicky) 
  • MOSSER, David M.; EDWARDS, Justin P. Exploring the full spectrum of macrophage activation. Nature Reviews Immunology. 2008-12, roč. 8, čís. 12, s. 958–969. Dostupné online [cit. 2019-04-30]. ISSN 1474-1733. doi:10.1038/nri2448. PMID 19029990. (anglicky) 
  • PENG, W.; LIU, C.; XU, C. PD-1 Blockade Enhances T-cell Migration to Tumors by Elevating IFN- Inducible Chemokines. Cancer Research. 2012-10-15, roč. 72, čís. 20, s. 5209–5218. Dostupné online [cit. 2019-04-30]. ISSN 0008-5472. doi:10.1158/0008-5472.CAN-12-1187. PMID 22915761. (anglicky) 
  • BEDOGNETTI, D; SPIVEY, T L; ZHAO, Y. CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2. British Journal of Cancer. 2013-10, roč. 109, čís. 9, s. 2412–2423. Dostupné online [cit. 2019-04-30]. ISSN 0007-0920. doi:10.1038/bjc.2013.557. PMID 24129241. (anglicky) 

elsevier.com (Global: 610th place; Czech: 203rd place)

linkinghub.elsevier.com

jci.org (Global: low place; Czech: 7,867th place)

  • ZOHAR, Yaniv; WILDBAUM, Gizi; NOVAK, Rostislav. CXCL11-dependent induction of FOXP3-negative regulatory T cells suppresses autoimmune encephalomyelitis. Journal of Clinical Investigation. 2014-05-01, roč. 124, čís. 5, s. 2009–2022. Dostupné online [cit. 2019-04-30]. ISSN 0021-9738. doi:10.1172/JCI71951. PMID 24713654. (anglicky) 

jimmunol.org (Global: low place; Czech: 5,054th place)

  • GORBACHEV, A. V.; KOBAYASHI, H.; KUDO, D. CXC Chemokine Ligand 9/Monokine Induced by IFN- Production by Tumor Cells Is Critical for T Cell-Mediated Suppression of Cutaneous Tumors. The Journal of Immunology. 2007-02-15, roč. 178, čís. 4, s. 2278–2286. Dostupné online [cit. 2019-04-30]. ISSN 0022-1767. doi:10.4049/jimmunol.178.4.2278. (anglicky) 

nature.com (Global: 234th place; Czech: 72nd place)

nih.gov (Global: 4th place; Czech: 8th place)

ncbi.nlm.nih.gov

oncotarget.com (Global: low place; Czech: 6,523rd place)

wiley.com (Global: 222nd place; Czech: 83rd place)

doi.wiley.com

  • OGHUMU, Steve; VARIKUTI, Sanjay; TERRAZAS, Cesar. CXCR3 deficiency enhances tumor progression by promoting macrophage M2 polarization in a murine breast cancer model. Immunology. 2014-9, roč. 143, čís. 1, s. 109–119. Dostupné online [cit. 2019-04-30]. doi:10.1111/imm.12293. PMID 24679047. (anglicky) 

worldcat.org (Global: 5th place; Czech: 3rd place)

  • FERNANDEZ-POMA, Sarita M.; SALAS-BENITO, Diego; LOZANO, Teresa. Expansion of Tumor-Infiltrating CD8 + T cells Expressing PD-1 Improves the Efficacy of Adoptive T-cell Therapy. Cancer Research. 2017-07-01, roč. 77, čís. 13, s. 3672–3684. Dostupné online [cit. 2019-04-30]. ISSN 0008-5472. doi:10.1158/0008-5472.CAN-17-0236. (anglicky) 
  • ZHU, Guiquan; YAN, H. Hannah; PANG, Yanli. CXCR3 as a molecular target in breast cancer metastasis: inhibition of tumor cell migration and promotion of host anti-tumor immunity. Oncotarget. 2015-12-22, roč. 6, čís. 41. Dostupné online [cit. 2019-04-30]. ISSN 1949-2553. doi:10.18632/oncotarget.6125. PMID 26485767. (anglicky) 
  • GORBACHEV, A. V.; KOBAYASHI, H.; KUDO, D. CXC Chemokine Ligand 9/Monokine Induced by IFN- Production by Tumor Cells Is Critical for T Cell-Mediated Suppression of Cutaneous Tumors. The Journal of Immunology. 2007-02-15, roč. 178, čís. 4, s. 2278–2286. Dostupné online [cit. 2019-04-30]. ISSN 0022-1767. doi:10.4049/jimmunol.178.4.2278. (anglicky) 
  • ZOHAR, Yaniv; WILDBAUM, Gizi; NOVAK, Rostislav. CXCL11-dependent induction of FOXP3-negative regulatory T cells suppresses autoimmune encephalomyelitis. Journal of Clinical Investigation. 2014-05-01, roč. 124, čís. 5, s. 2009–2022. Dostupné online [cit. 2019-04-30]. ISSN 0021-9738. doi:10.1172/JCI71951. PMID 24713654. (anglicky) 
  • MOSSER, David M.; EDWARDS, Justin P. Exploring the full spectrum of macrophage activation. Nature Reviews Immunology. 2008-12, roč. 8, čís. 12, s. 958–969. Dostupné online [cit. 2019-04-30]. ISSN 1474-1733. doi:10.1038/nri2448. PMID 19029990. (anglicky) 
  • PENG, W.; LIU, C.; XU, C. PD-1 Blockade Enhances T-cell Migration to Tumors by Elevating IFN- Inducible Chemokines. Cancer Research. 2012-10-15, roč. 72, čís. 20, s. 5209–5218. Dostupné online [cit. 2019-04-30]. ISSN 0008-5472. doi:10.1158/0008-5472.CAN-12-1187. PMID 22915761. (anglicky) 
  • BEDOGNETTI, D; SPIVEY, T L; ZHAO, Y. CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2. British Journal of Cancer. 2013-10, roč. 109, čís. 9, s. 2412–2423. Dostupné online [cit. 2019-04-30]. ISSN 0007-0920. doi:10.1038/bjc.2013.557. PMID 24129241. (anglicky)